Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam · Delayed Price · Currency is VND 24,300
+1,000 (4.29%)
At close: Jul 17, 2025
Exscientia Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Net Income | - | 15,183 | 11,837 | 6,366 | 3,747 | 24,422 | Upgrade |
Depreciation & Amortization | - | 7,906 | 8,444 | 10,020 | 9,536 | 10,020 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -6,344 | -3,782 | -3,902 | -4,102 | Upgrade |
Other Operating Activities | - | 1,554 | -1,776 | 1,683 | -2,016 | -3,885 | Upgrade |
Change in Accounts Receivable | - | 21,106 | 274.47 | 2,063 | 58,829 | 63,652 | Upgrade |
Change in Inventory | - | 15,243 | -1,554 | -14,664 | 4,843 | 39,261 | Upgrade |
Change in Accounts Payable | - | -27,649 | -60,719 | 26,049 | -6,766 | -42,537 | Upgrade |
Change in Other Net Operating Assets | - | 1,368 | 3,482 | -1,503 | -2,160 | 2,524 | Upgrade |
Operating Cash Flow | - | 34,710 | -46,356 | 26,231 | 62,110 | 89,354 | Upgrade |
Operating Cash Flow Growth | - | - | - | -57.77% | -30.49% | -23.00% | Upgrade |
Capital Expenditures | - | - | -38,092 | -117,270 | -54,364 | -28,827 | Upgrade |
Sale of Property, Plant & Equipment | - | 915.16 | 268.82 | 240.21 | 992.27 | 8.18 | Upgrade |
Investment in Securities | - | 8,000 | 72,400 | -44,000 | 6,000 | - | Upgrade |
Other Investing Activities | - | 931.33 | 6,929 | 3,354 | 3,479 | 3,376 | Upgrade |
Investing Cash Flow | - | 9,846 | 41,505 | -157,676 | -43,893 | -54,843 | Upgrade |
Short-Term Debt Issued | - | 157,753 | 193,594 | 205,142 | 180,305 | 218,086 | Upgrade |
Total Debt Issued | - | 157,753 | 193,594 | 205,142 | 180,305 | 218,086 | Upgrade |
Short-Term Debt Repaid | - | -194,430 | -219,966 | -182,973 | -192,316 | -233,080 | Upgrade |
Total Debt Repaid | - | -194,430 | -219,966 | -182,973 | -192,316 | -233,080 | Upgrade |
Net Debt Issued (Repaid) | - | -36,676 | -26,372 | 22,168 | -12,012 | -14,995 | Upgrade |
Issuance of Common Stock | - | - | - | 153,104 | - | - | Upgrade |
Common Dividends Paid | - | -8,802 | -6,426 | -8,816 | -13,281 | -9,307 | Upgrade |
Financing Cash Flow | - | -45,478 | -32,799 | 166,456 | -25,293 | -24,302 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | - | -28.96 | - | 10.42 | Upgrade |
Net Cash Flow | - | -922.47 | -37,650 | 34,983 | -7,076 | 10,219 | Upgrade |
Free Cash Flow | - | 34,710 | -84,449 | -91,039 | 7,746 | 60,527 | Upgrade |
Free Cash Flow Growth | - | - | - | - | -87.20% | -38.65% | Upgrade |
Free Cash Flow Margin | - | 7.83% | -21.11% | -22.70% | 2.25% | 11.61% | Upgrade |
Free Cash Flow Per Share | - | 2795.95 | -6805.99 | -9696.32 | 1234.13 | 9638.35 | Upgrade |
Cash Interest Paid | - | 2,396 | 5,432 | 4,953 | 3,643 | 4,302 | Upgrade |
Cash Income Tax Paid | - | 3,874 | 4,719 | 272.58 | 2,383 | 9,020 | Upgrade |
Levered Free Cash Flow | - | 40,459 | -98,454 | -115,881 | 14,442 | 45,357 | Upgrade |
Unlevered Free Cash Flow | - | 41,970 | -95,082 | -112,754 | 16,703 | 48,992 | Upgrade |
Change in Net Working Capital | -42,613 | -20,243 | 74,265 | 10,900 | -55,975 | -50,786 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.